Mark Brody
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Physiology top 10%
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 3
-
- Cholinesterase and Neurodegenerative Diseases 2
- Co-authors
- Craig Curtis (3 shared papers)Jeffrey L. Cummings (2 shared papers)Yong‐Yeon Cho (1 shared paper)Reina N. Fuji (1 shared paper)Christina Rabe (1 shared paper)Michel Friesenhahn (1 shared paper)David Clayton (1 shared paper)Christopher H. van Dyck (1 shared paper)
- Journals
- Alzheimer s & Dementia (8 papers)Neurology (3 papers)The FASEB Journal (1 paper)Stroke (1 paper)Journal of Alzheimer s Disease (1 paper)
- Partner nations
- United StatesSwedenBelgium
In The Last Decade
Mark Brody
14 papers receiving 381 citations
Peers
Comparison fields: 5 of 60
- Biological Psychiatry 32
- Physiology 172
- Psychiatry and Mental health 72
- Neurology 37
- Pharmacology 69
Countries citing papers authored by Mark Brody
This map shows the geographic impact of Mark Brody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Brody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Brody more than expected).
Fields of papers citing papers by Mark Brody
This network shows the impact of papers produced by Mark Brody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Brody. The network helps show where Mark Brody may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Brody, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 195 | |
| 2 | 2022 | 41 | |
| 3 | 1994 | 40 | |
| 4 | 1998 | 38 | |
| 5 | 1997 | 30 | |
| 6 | 2016 | 27 | |
| 7 | 2013 | 8 | |
| 8 | 2011 | 4 | |
| 9 | 2009 | 2 | |
| 10 | 2016 | 1 | |
| 11 | 2020 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2011 | 1 |
About Mark Brody
Mark Brody is a scholar working on Physiology, Pharmacology, Epidemiology, Psychiatry and Mental health and Genetics, having authored 14 papers that have together received 390 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Acute Ischemic Stroke Management (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper), Neuroethics, Human Enhancement, Biomedical Innovations (1 paper), Autism Spectrum Disorder Research (1 paper) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Biological Psychiatry (32 citations), Physiology (172 citations), Psychiatry and Mental health (72 citations), Neurology (37 citations) and Pharmacology (69 citations). Mark Brody has collaborated with scholars based in United States, Sweden and Belgium. Frequent co-authors include Craig Curtis, Jeffrey L. Cummings, Yong‐Yeon Cho, Reina N. Fuji, Christina Rabe, Michel Friesenhahn, David Clayton, Christopher H. van Dyck, Richard M. Zweifler and Robert Paul. Their work appears in journals such as Alzheimer s & Dementia, Neurology, The FASEB Journal, Stroke and Journal of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.